Clinical Trial Update: Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

Phase 1b/2a study of GSBR-1290 in adults with obesity and Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• GSBR-1290

Snippet

Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | Conditions: Overweight or Obesity, Type2 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED